Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|August 7, 2008
[Establishment of a cellular model with human NADH-cytochrome b5 reductase deficiency via RNA interference]Yuepeng Zhuang, Shuiliang Wang, Fenghua Lan
Advances in Experimental Medicine and Biology|October 30, 2020
Neuregulin Signaling in the Tumor MicroenvironmentRuxue Jia, Hu Zhao, Shuiliang Wang
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 17, 2015
Determination of ultra-trace organic acids in Masson pine (Pinus massoniana L.) by accelerated solvent extraction and liquid chromatography-tandem mass spectrometryShuiliang Wang, China Q Fan, Ping Wang
Cytotherapy|June 12, 2013
Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerationsJin Wang, Lianming Liao, Shuiliang Wang, et al.
Chinese Medical Journal|September 7, 2002
Effect of N,N'-dinitrosopiperazine on in vitro expression of human cytochrome P450 2E1Jianhua Zhu, Zhimin He, Shuiliang Wang, et al.
Organic & Biomolecular Chemistry|October 20, 2020
Conversions of aryl carboxylic acids into aryl nitriles using multiple types of Cu-mediated decarboxylative cyanation under aerobic conditionsZhengjiang Fu, Xihan Cao, Shuiliang Wang, et al.
Translational Cancer Research|February 4, 2022
Pazopanib as salvage therapy in metastatic renal cell carcinoma with hypercalcemic crisis and renal insufficiency: a case report and literature reviewYing Chen, Xiaoming Ling, Wencui Kong, et al.
Environmental Monitoring and Assessment|December 8, 2011
Distributions of phthalic esters carried by total suspended particulates in Nanjing, ChinaWenxin Wang, Yinlong Zhang, Shuiliang Wang, et al.
Cancer Letters|May 8, 2010
HDAC inhibition synergistically enhances alkylator-induced DNA damage responses and apoptosis in multiple myeloma cellsChoon-Kee Lee, Shuiliang Wang, Xiaoping Huang, et al.
Cancer Letters|April 19, 2011
HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistanceXiaoping Huang, Shuiliang Wang, Choon-Kee Lee, et al.
Pageof 5